{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T03:59:00Z","timestamp":1754193540116},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,25]]},"DOI":"10.7759\/cureus.26323","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T13:19:55Z","timestamp":1656163195000},"source":"Crossref","is-referenced-by-count":4,"title":["An Innovative Approach to the Diagnosis of Cardiac Angiosarcoma"],"prefix":"10.7759","author":[{"given":"Samuel","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Dimza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennie","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/208929","article-title":"Cardiac tumors","volume":"2011","author":"Paraskevaidis IA","year":"2011","unstructured":"Paraskevaidis IA, Michalakeas CA, Papadopoulos CH, Anastasiou-Nana M. Cardiac tumors. ISRN Oncol. 2011, 2011:208929. 10.5402\/2011\/208929","journal-title":"ISRN Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2010.03.065","article-title":"Primary cardiac sarcoma","volume":"90","author":"Hamidi M","year":"2010","unstructured":"Hamidi M, Moody JS, Weigel TL, Kozak KR. Primary cardiac sarcoma. Ann Thorac Surg. 2010, 90:176-81. 10.1016\/j.athoracsur.2010.03.065","journal-title":"Ann Thorac Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)89149-7","article-title":"Frequency of primary tumors of the heart","volume":"77","author":"Reynen K","year":"1996","unstructured":"Reynen K. Frequency of primary tumors of the heart. Am J Cardiol. 1996, 77:107. 10.1016\/S0002-9149(97)89149-7","journal-title":"Am J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2084390","article-title":"A patient presenting with cardiac tamponade and the challenges of finding its cause: a cardiac angiosarcoma","volume":"2018","author":"Habibi R","year":"2018","unstructured":"Habibi R, Faramarzi N, Altamirano AJ, Dadkhah S. A patient presenting with cardiac tamponade and the challenges of finding its cause: a cardiac angiosarcoma. Case Rep Cardiol. 2018, 2018:2084390. 10.1155\/2018\/2084390","journal-title":"Case Rep Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.31486\/toj.17.0081","article-title":"Beyond Beck's triad: a rare cause of cardiac tamponade and hemoptysis","volume":"18","author":"Pacha HM","year":"2018","unstructured":"Pacha HM, Soud M, Alraies MC. Beyond Beck's triad: a rare cause of cardiac tamponade and hemoptysis. Ochsner J. 2018, 18:271-3. 10.31486\/toj.17.0081","journal-title":"Ochsner J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2018.01.005","article-title":"Mediastinal angiosarcoma presenting as diffuse alveolar hemorrhage","volume":"23","author":"Datta D","year":"2018","unstructured":"Datta D, Gerardi DA, Lahiri B. Mediastinal angiosarcoma presenting as diffuse alveolar hemorrhage. Respir Med Case Rep. 2018, 23:115-7. 10.1016\/j.rmcr.2018.01.005","journal-title":"Respir Med Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1426.2018.08.009","article-title":"Pulmonary metastatic angiosarcoma presenting with diffuse alveolar hemorrhage: 9 case reports. (Article in Chinese)","volume":"57","author":"Wang HP","year":"2018","unstructured":"Wang HP, Shi JH, Wang WZ, Zhang L. Pulmonary metastatic angiosarcoma presenting with diffuse alveolar hemorrhage: 9 case reports. (Article in Chinese). Zhonghua Nei Ke Za Zhi. 2018, 57:582-7. 10.3760\/cma.j.issn.0578-1426.2018.08.009","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0489-5","article-title":"Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors","volume":"7","author":"Conroy JM","year":"2019","unstructured":"Conroy JM, Pabla S, Nesline MK, et al.. Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. J Immunother Cancer. 2019, 7:18. 10.1186\/s40425-018-0489-5","journal-title":"J Immunother Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00753-2","article-title":"Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing","volume":"12","author":"Boichard A","year":"2020","unstructured":"Boichard A, Wagner MJ, Kurzrock R. Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing. Genome Med. 2020, 12:61. 10.1186\/s13073-020-00753-2","journal-title":"Genome Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0263-0","article-title":"Angiosarcoma treated successfully with anti-PD-1 therapy - a case report","volume":"5","author":"Sindhu S","year":"2017","unstructured":"Sindhu S, Gimber LH, Cranmer L, McBride A, Kraft AS. Angiosarcoma treated successfully with anti-PD-1 therapy - a case report. J Immunother Cancer. 2017, 5:58. 10.1186\/s40425-017-0263-0","journal-title":"J Immunother Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00071","article-title":"Association between programmed death-ligand 1 expression and the vascular endothelial growth factor pathway in angiosarcoma","volume":"8","author":"Bagaria SP","year":"2018","unstructured":"Bagaria SP, Gatalica Z, Maney T, et al.. Association between programmed death-ligand 1 expression and the vascular endothelial growth factor pathway in angiosarcoma. Front Oncol. 2018, 8:71. 10.3389\/fonc.2018.00071","journal-title":"Front Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7150\/jca.19060","article-title":"Programmed death ligand 1 (PD-L1) expression in primary angiosarcoma","volume":"8","author":"Botti G","year":"2017","unstructured":"Botti G, Scognamiglio G, Marra L, et al.. Programmed death ligand 1 (PD-L1) expression in primary angiosarcoma. J Cancer. 2017, 8:3166-72. 10.7150\/jca.19060","journal-title":"J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5146\/tjpath.2017.01395","article-title":"Programmed death ligand 1 (PD-L1) expression in malignant mesenchymal tumors","volume":"33","author":"K\u00f6semehmeto\u011flu K","year":"2017","unstructured":"K\u00f6semehmeto\u011flu K, \u00d6zo\u011ful E, Babao\u011flu B, Tezel GG, Gediko\u011flu G. Programmed death ligand 1 (PD-L1) expression in malignant mesenchymal tumors. Turk Patoloji Derg. 2017, 33:192-7. 10.5146\/tjpath.2017.01395","journal-title":"Turk Patoloji Derg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.733","article-title":"Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience","volume":"78","author":"Llombart-Cussac A","year":"1998","unstructured":"Llombart-Cussac A, Pivot X, Contesso G, et al.. Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience. Br J Cancer. 1998, 78:1624-8. 10.1038\/bjc.1998.733","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio0653","article-title":"Therapy insight: malignant primary cardiac tumors","volume":"3","author":"Reardon MJ","year":"2006","unstructured":"Reardon MJ, Walkes JC, Benjamin R. Therapy insight: malignant primary cardiac tumors. Nat Clin Pract Cardiovasc Med. 2006, 3:548-53. 10.1038\/ncpcardio0653","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-016-0540-x","article-title":"Survival after heart transplantation for non-metastatic primary cardiac sarcoma","volume":"11","author":"Li H","year":"2016","unstructured":"Li H, Yang S, Chen H, Yang Z, Hong T, Hou Y, Wang C. Survival after heart transplantation for non-metastatic primary cardiac sarcoma. J Cardiothorac Surg. 2016, 11:145. 10.1186\/s13019-016-0540-x","journal-title":"J Cardiothorac Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/57222-an-innovative-approach-to-the-diagnosis-of-cardiac-angiosarcoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:21Z","timestamp":1707507501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/57222-an-innovative-approach-to-the-diagnosis-of-cardiac-angiosarcoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.26323","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,25]]}}}